Smolianskaia A Z
Antibiot Med Biotekhnol. 1986 Jan;31(1):43-9.
The poly-etiologic profile of cancer patients and poly-resistance of pathogens causing infections in them are the features defining disease-specific infectious complications. Such pathogens are isolated from both monocultures and associations depending on the infection localization. The taxonomic position of the pathogens defines the level of their poly-resistance. The etiologic structure of the infections and the pathogen sensitivity spectrum change in time. In this connection the choice of antibacterial drugs for treatment of infections in cancer patients should be grounded by the data on bacteriological assays of pathological specimens from individual patients or by the combined data on bacteriological assays of analogous pathological specimens from a group of similar patients.
癌症患者的多病因特征以及导致其感染的病原体的多重耐药性是界定特定疾病感染并发症的特征。根据感染部位的不同,这些病原体可从单一培养物和混合培养物中分离出来。病原体的分类地位决定了其多重耐药水平。感染的病因结构和病原体敏感性谱会随时间变化。因此,治疗癌症患者感染时抗菌药物的选择应以个体患者病理标本的细菌学检测数据或一组类似患者的类似病理标本细菌学检测综合数据为依据。